A woman in a dress letting go of colorful balloons

Pioneering Science for Patient Choice

Pharvaris

aims to

set people living with HAE free

We aim to provide

freedom from angioedema symptoms and attacks

We aim to provide

freedom from injections

We aim to provide

injectable-like efficacy™ and a well-tolerated profile in oral therapies

Our Approach

Harnessing established science to advance oral therapies for bradykinin mediated diseases.

View our Science
Deucrictibant molecular structure

Pharvaris aims to deliver oral bradykinin B2 receptor antagonists to help address unmet needs and improve standard of care.

View our Pipeline

At Pharvaris, we understand the impact of a rare disease; we aim to address existing unmet needs and provide choices for those living with bradykinin-mediated diseases.

Our Disease Focus
A microscopic view of a complex molecular structure

Pharvarians are committed to those whose lives are impacted by bradykinin-mediated diseases, and value our relationships with the organizations that offer support.

HAE Community

Our legacy, scientific expertise, and values drive our passion as we aspire to provide choice to people living with bradykinin-mediated diseases.

About Us